Clinical Trial Update: Empagliflozin vs Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome With or Without Comorbidity or Multimorbidity [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reports a completed Phase 2/3 study comparing empagliflozin to metformin for metabolic dysfunction in polycystic ovary syndrome. The updat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Jardiance (empagliflozin)
• metformin (metformin)

Snippet

Sponsor: SINA Health Education and Welfare Trust | Conditions: Polycystic Ovary Syndrome, Weight Gain | Phase 2, Phase 3 | Status: COMPLETED